Bulletin
Investor Alert

Abbott Laboratories

NYS: ABT

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 14, 2021, 6:39 p.m.

ABT
/zigman2/quotes/203724446/composite

$

118.31

Change

0.00 0.00%

Volume

Volume 440,157

Quotes are delayed by 20 min

/zigman2/quotes/203724446/composite

Previous close

$ 117.45

$ 118.31

Change

+0.86 +0.73%

Day low

Day high

$117.33

$118.82

Open

52 week low

52 week high

$86.16

$128.54

Open

Company Description

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Medical Devices. The Established P...

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Valuation

P/E Current

47.24

P/E Ratio (with extraordinary items)

37.21

P/E Ratio (without extraordinary items)

43.72

Price to Sales Ratio

5.65

Price to Book Ratio

5.92

Price to Cash Flow Ratio

24.75

Enterprise Value to EBITDA

24.06

Enterprise Value to Sales

6.02

Total Debt to Enterprise Value

0.10

Efficiency

Revenue/Employee

317,505.00

Income Per Employee

40,817.00

Receivables Turnover

5.85

Total Asset Turnover

0.49

Liquidity

Current Ratio

1.72

Quick Ratio

1.30

Cash Ratio

0.60

Profitability

Gross Margin

50.21

Operating Margin

15.29

Pretax Margin

14.36

Net Margin

12.86

Return on Assets

6.34

Return on Equity

13.93

Return on Total Capital

10.24

Return on Invested Capital

8.83

Capital Structure

Total Debt to Total Equity

60.67

Total Debt to Total Capital

37.76

Total Debt to Total Assets

27.42

Long-Term Debt to Equity

59.26

Long-Term Debt to Total Capital

36.89

Officers and Executives

Name Age Officer Since Title
Mr. Miles D. White 64 1984 Director & Executive Vice President
Mr. Robert B. Ford 45 - President & Chief Operating Officer
Mr. Robert E. Funck 57 1987 Vice President & Treasurer
Dr. Gene Huang - - Chief Economist & Vice President
Ms. Lisa D. Earnhardt 50 - Executive Vice President-Medical Devices

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
04/30/2021 Jared L. Watkin
SENIOR VICE PRESIDENT
85,043   Disposition at $119.89 per share. 10,195,805
04/30/2021 Jared L. Watkin
SENIOR VICE PRESIDENT
9,533   Disposition at $120.02 per share. 1,144,150
04/30/2021 Jared L. Watkin
SENIOR VICE PRESIDENT
68,000   Derivative/Non-derivative trans. at $59.94 per share. 4,075,920
04/30/2021 Jared L. Watkin
SENIOR VICE PRESIDENT
17,043   Derivative/Non-derivative trans. at $44.4 per share. 756,709
04/28/2021 Robert E. Funck
EXECUTIVE VICE PRESIDENT
700   Gift at $0 per share. 0
04/27/2021 Roger Bird
SENIOR VICE PRESIDENT
9,439   Disposition at $122 per share. 1,151,558
04/27/2021 Sammy Karam
SENIOR VICE PRESIDENT
8,600   Disposition at $122 per share. 1,049,200
04/27/2021 Sammy Karam
SENIOR VICE PRESIDENT
8,600   Derivative/Non-derivative trans. at $75.9 per share. 652,740
04/23/2021 Daniel J. Starks
Director
1,499   Award at $0 per share. 0
04/23/2021 William A. Osborn
Director
1,499   Award at $0 per share. 0
04/23/2021 Glenn Fletcher Tilton
Director
1,499   Award at $0 per share. 0
04/23/2021 Roxanne Schuh Austin
Director
1,499   Award at $0 per share. 0
04/23/2021 Robert J. Alpern
Director
1,499   Award at $0 per share. 0
04/23/2021 Sally E. Blount
Director
1,499   Award at $0 per share. 0
04/23/2021 Nancy McKinstry
Director
1,499   Award at $0 per share. 0
04/23/2021 John G. Stratton
Director
1,499   Award at $0 per share. 0
04/23/2021 Michelle A. Kumbier
Director
1,499   Award at $0 per share. 0
04/23/2021 Darren W. McDew
Director
1,499   Award at $0 per share. 0
04/23/2021 Michael F. Roman
Director
1,499   Award at $0 per share. 0
04/01/2021 Randel William Woodgrift
SENIOR VICE PRESIDENT
1,368   Derivative/Non-derivative trans. at $119.84 per share. 163,941
04/01/2021 Christopher Scoggins
SENIOR VICE PRESIDENT
1,223   Derivative/Non-derivative trans. at $119.84 per share. 146,564
03/03/2021 Andrea Wainer
EXECUTIVE VICE PRESIDENT
6,200   Disposition at $121.79 per share. 755,098
03/01/2021 Daniel Gesua Sive Salvadori
EXECUTIVE VICE PRESIDENT
1,664   Disposition at $120.61 per share. 200,695
03/01/2021 John F. Ginascol
EXECUTIVE VICE PRESIDENT
352   Disposition at $120.61 per share. 42,454
03/01/2021 Lisa D. Earnhardt
EXECUTIVE VICE PRESIDENT
943   Disposition at $120.61 per share. 113,735
03/01/2021 Jared L. Watkin
SENIOR VICE PRESIDENT
1,391   Disposition at $120.61 per share. 167,768
03/01/2021 Randel William Woodgrift
SENIOR VICE PRESIDENT
1,034   Disposition at $120.61 per share. 124,710
03/01/2021 Andrea Wainer
EXECUTIVE VICE PRESIDENT
587   Disposition at $120.61 per share. 70,798
03/01/2021 Roger Bird
SENIOR VICE PRESIDENT
1,113   Disposition at $120.61 per share. 134,238
03/01/2021 Charles Brynelsen
SENIOR VICE PRESIDENT
1,002   Disposition at $120.61 per share. 120,851
03/01/2021 Michael D. Dale
SENIOR VICE PRESIDENT
1,475   Disposition at $120.61 per share. 177,899
03/01/2021 Gregory A. Ahlberg
SENIOR VICE PRESIDENT
1,052   Disposition at $120.61 per share. 126,881
02/26/2021 Miles D. White
EXECUTIVE CHAIRMAN; Director
43,292   Derivative/Non-derivative trans. at $121.58 per share. 5,263,441
02/26/2021 John M. Capek
EXECUTIVE VICE PRESIDENT
9,267   Derivative/Non-derivative trans. at $121.58 per share. 1,126,681
02/26/2021 Robert B. Ford
PRESIDENT AND CEO; Director
22,865   Derivative/Non-derivative trans. at $121.58 per share. 2,779,926
02/26/2021 Robert E. Funck
EXECUTIVE VICE PRESIDENT
10,136   Derivative/Non-derivative trans. at $121.58 per share. 1,232,334
02/26/2021 Hubert L. Allen
EXECUTIVE VICE PRESIDENT
10,913   Derivative/Non-derivative trans. at $121.58 per share. 1,326,802
02/26/2021 Daniel Gesua Sive Salvadori
EXECUTIVE VICE PRESIDENT
12,596   Derivative/Non-derivative trans. at $121.58 per share. 1,531,421
02/26/2021 John F. Ginascol
EXECUTIVE VICE PRESIDENT
4,736   Derivative/Non-derivative trans. at $121.58 per share. 575,802
02/26/2021 Andrew Herbert Lane
EXECUTIVE VICE PRESIDENT
5,065   Derivative/Non-derivative trans. at $121.58 per share. 615,802
02/26/2021 Mary K. Moreland
EXECUTIVE VICE PRESIDENT
2,116   Derivative/Non-derivative trans. at $121.58 per share. 257,263
02/26/2021 Lisa D. Earnhardt
EXECUTIVE VICE PRESIDENT
2,621   Derivative/Non-derivative trans. at $121.58 per share. 318,661
02/26/2021 Joseph J Manning
SENIOR VICE PRESIDENT
5,974   Derivative/Non-derivative trans. at $121.58 per share. 726,318
02/26/2021 Michael J. Pederson
SENIOR VICE PRESIDENT
6,246   Derivative/Non-derivative trans. at $121.58 per share. 759,388
02/26/2021 Jared L. Watkin
SENIOR VICE PRESIDENT
9,433   Derivative/Non-derivative trans. at $121.58 per share. 1,146,864
02/26/2021 Randel William Woodgrift
SENIOR VICE PRESIDENT
4,135   Derivative/Non-derivative trans. at $121.58 per share. 502,733
02/26/2021 Andrea Wainer
EXECUTIVE VICE PRESIDENT
5,000   Derivative/Non-derivative trans. at $121.58 per share. 607,900
02/26/2021 Roger Bird
SENIOR VICE PRESIDENT
7,999   Derivative/Non-derivative trans. at $121.58 per share. 972,518
02/26/2021 Christopher Scoggins
SENIOR VICE PRESIDENT
4,846   Derivative/Non-derivative trans. at $121.58 per share. 589,176
02/26/2021 Charles Brynelsen
SENIOR VICE PRESIDENT
7,060   Derivative/Non-derivative trans. at $121.58 per share. 858,354
02/26/2021 Michael D. Dale
SENIOR VICE PRESIDENT
4,000   Derivative/Non-derivative trans. at $121.58 per share. 486,320
02/26/2021 Alejandro Diego Wellisch
SENIOR VICE PRESIDENT
5,612   Derivative/Non-derivative trans. at $121.58 per share. 682,306
02/26/2021 Philip P. Boudreau
VICE PRESIDENT
704   Derivative/Non-derivative trans. at $121.58 per share. 85,592
02/26/2021 Gregory A. Ahlberg
SENIOR VICE PRESIDENT
2,282   Derivative/Non-derivative trans. at $121.58 per share. 277,445
02/26/2021 Sammy Karam
SENIOR VICE PRESIDENT
3,910   Derivative/Non-derivative trans. at $121.58 per share. 475,377
02/26/2021 Andrew Herbert Lane
EXECUTIVE VICE PRESIDENT
25,319   Award at $0 per share. 0
02/26/2021 Alejandro Diego Wellisch
SENIOR VICE PRESIDENT
16,032   Award at $0 per share. 0
02/26/2021 Sammy Karam
SENIOR VICE PRESIDENT
9,772   Award at $0 per share. 0
02/23/2021 Michelle A. Kumbier
Director
2,040   Acquisition at $122.5 per share. 249,900
02/22/2021 Mary K. Moreland
EXECUTIVE VICE PRESIDENT
400   Disposition at $121.84 per share. 48,736
02/22/2021 Mary K. Moreland
EXECUTIVE VICE PRESIDENT
780   Derivative/Non-derivative trans. at $123.04 per share. 95,971
02/22/2021 Philip P. Boudreau
VICE PRESIDENT
937   Derivative/Non-derivative trans. at $123.04 per share. 115,288
/news/latest/company/us/abt

MarketWatch News on ABT

  1. Abbott Laboratories stock rises Friday, still underperforms market

    4:33 p.m. May 14, 2021

    - MarketWatch Automation

  2. Abbott Laboratories stock rises Thursday, still underperforms market

    4:33 p.m. May 13, 2021

    - MarketWatch Automation

  3. Abbott Laboratories stock falls Wednesday, still outperforms market

    4:33 p.m. May 12, 2021

    - MarketWatch Automation

  4. Abbott Laboratories stock outperforms market despite losses on the day

    4:33 p.m. May 11, 2021

    - MarketWatch Automation

  5. Abbott Laboratories stock underperforms Monday when compared to competitors

    4:33 p.m. May 10, 2021

    - MarketWatch Automation

  6. Abbott Laboratories stock rises Friday, still underperforms market

    4:33 p.m. May 7, 2021

    - MarketWatch Automation

  7. Abbott Laboratories stock rises Thursday, still underperforms market

    4:33 p.m. May 6, 2021

    - MarketWatch Automation

  8. Abbott Laboratories stock rises Wednesday, outperforms market

    4:33 p.m. May 5, 2021

    - MarketWatch Automation

  9. Abbott Laboratories stock falls Friday, underperforms market

    4:33 p.m. April 30, 2021

    - MarketWatch Automation

  10. Abbott Laboratories stock underperforms Thursday when compared to competitors

    4:33 p.m. April 29, 2021

    - MarketWatch Automation

  11. Abbott Laboratories stock falls Wednesday, underperforms market

    4:33 p.m. April 28, 2021

    - MarketWatch Automation

  12. Abbott Laboratories stock falls Tuesday, underperforms market

    4:34 p.m. April 27, 2021

    - MarketWatch Automation

  13. Abbott Laboratories stock falls Monday, underperforms market

    4:33 p.m. April 26, 2021

    - MarketWatch Automation

  14. Abbott Laboratories stock falls Friday, underperforms market

    4:33 p.m. April 23, 2021

    - MarketWatch Automation

  15. Abbott Laboratories stock rises Thursday, outperforms market

    4:33 p.m. April 22, 2021

    - MarketWatch Automation

  16. Abbott Laboratories stock outperforms competitors on strong trading day

    4:33 p.m. April 21, 2021

    - MarketWatch Automation

  17. Abbott Laboratories stock underperforms Tuesday when compared to competitors

    4:33 p.m. April 20, 2021

    - MarketWatch Automation

  18. Dow ends lower for 2nd day as investors look past earnings beats

    4:20 p.m. April 20, 2021

    - William Watts

  19. Loading more headlines...
/news/nonmarketwatch/company/us/abt

Other News on ABT

  1. 3 High-Yield Dividend Stocks I'd Buy Right Now

    6:01 a.m. May 16, 2021

    - Motley Fool

  2. These 3 Things Make a Healthcare Stock Evergreen

    6:25 a.m. May 15, 2021

    - Motley Fool

  3. If You Do the Math, Senseonics Makes No Sense

    1:19 p.m. May 14, 2021

    - InvestorPlace.com

  4. Quest Diagnostics (DGX) Expands COVID-19 Test Eligibility

    10:10 a.m. May 14, 2021

    - Zacks.com

  5. 3 Dividend Stocks That Pay You Better Than Coca-Cola Does

    6:20 a.m. May 14, 2021

    - Motley Fool

  6. 7 Great Growth Stocks to Consider for Your Short List

    11:14 a.m. May 12, 2021

    - InvestorPlace.com

  7. Senseonics: Product Strength And Marketing Alliance

    2:27 p.m. May 10, 2021

    - Seeking Alpha

  8. Wall Street Breakfast: The Week Ahead

    7:25 a.m. May 9, 2021

    - Seeking Alpha

  9. Dividend Challenger Highlights: Week Of May 9

    2:49 p.m. May 8, 2021

    - Seeking Alpha

  10. Is It Too Late to Buy AbbVie Stock in 2021?

    6:25 a.m. May 8, 2021

    - Motley Fool

  11. Seeking Alpha Catalyst Watch

    3:30 p.m. May 7, 2021

    - Seeking Alpha

  12. 10-Q: ABBOTT LABORATORIES

    4:03 p.m. May 5, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  13. Why Abbott Labs' Sizzling Growth Could Taper Off

    7:01 a.m. May 4, 2021

    - Motley Fool

  14. 2 Top Stocks to Buy and Hold for 10 Years

    6:48 a.m. May 4, 2021

    - Motley Fool

  15. Loading more headlines...

At a Glance

Abbott Laboratories

100 Abbott Park Road

Abbott Park, Illinois 60064-6400

Phone

1 2246676100

Industry

Pharmaceuticals

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2021

Revenue

$34.61B

Net Income

$4.45B

2020 Sales Growth

8.5%

Employees

109,000

/news/pressrelease/company/us/abt

Press Releases on ABT

  1. Laxatives Market Necessity And Demand 2020 to 2027

    5:10 a.m. May 15, 2021

    - Market Insight Reports

  2. Loading more headlines...
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.